As an investor, you are always on the lookout for opportunities to grow your portfolio. In today’s market, traditional investments like blue-chip stocks and bonds are not delivering the returns that they once did. As a result, many investors are turning to alternative investments, including emerging OTC stocks. In this blog, we will explore the benefits of investing in these stocks, and highlight four promising OTC stocks to watch: $LUDG, $IQST, $EDXC, and $MLRT.
What are OTC Stocks?
OTC stocks, also known as over-the-counter stocks, are stocks that are traded directly between two parties, rather than through a centralized exchange like the NYSE or NASDAQ. These stocks are often considered higher risk than traditional investments, as they are not subject to the same regulatory oversight as exchange-listed stocks. However, they also offer the potential for higher returns and growth opportunities.
Why Invest in OTC Stocks?
Investing in OTC stocks can be an attractive option for investors looking for high-growth opportunities in a shrinking market. While blue-chip stocks and bonds may be struggling to deliver returns, emerging OTC stocks can offer significant growth potential. These stocks are often smaller, less established companies that are looking to grow and expand. Their stock prices can rise as they grow, providing investors with significant returns.
Additionally, investing in OTC stocks can provide diversification benefits to your portfolio. By investing in a variety of OTC stocks, you can spread your investment risk and reduce your exposure to market fluctuations.
Four Promising OTC Stocks to Watch
1. $LUDG – Ludwig Enterprises, “The Genetic Language Company”, ™ is a publicly traded Genomics Technology Holding Company with Precision Genomics, Inc. and mRNA for Life, Inc. as wholly owned subsidiaries. Advancements in Biotechnology and Artificial Intelligence (AI) present cutting-edge genomic tools, unheard-of even a generation ago. These genomic tools have the potential to not only detect diseases early but also to potentially assist in improved patient outcomes and, in some cases, potentially even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic methodology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. This early analysis may assist patients and doctors to manage illness before it progresses and causes serious health problems. Precision Genomics’ innovative testing approach is not only practical but also has the potential to save the healthcare industry billions of dollars in costs. With a virtually untapped market and a billion-dollar healthcare industry, Ludwig Enterprises is potentially poised to significantly impact how we think about disease and live longer, healthier lives.
2. $IQST – iQSTEL Inc. (www.iQSTEL.com) is a US-based publicly listed company holding an Independent Board of Directors and Audit Committee with a presence in 19 countries and 70 employees offering leading-edge services through its four business lines. The Telecom Division (www.iqstelecom.com), which represents the majority of current operations, offers VoIP, SMS, proprietary Internet of Things (IoT) solutions, and international fiber-optic connectivity through its subsidiaries: Etelix, SwissLink, Smartbiz, Whisl, IoT Labs, and QGlobal SMS. The Fintech business line (www.globalmoneyone.com) (www.maxmo.vip) offers a complete Fintech ecosystem MasterCard Debit Card, US Bank Account (No SSN Needed), Mobile App/Wallet (Remittances, Mobile Top Up). Our Fintech subsidiary, Global Money One, is to provide immigrants access to reliable financial services that make it easier to manage their money and stay connected with their families back home. The BlockChain Platform Business Line (www.itsbchain.com) offers our proprietary Mobile Number Portability Application (MNPA) to serve the in-country portability needs through its subsidiary, itsBchain. The Electric Vehicle (EV) Business Line (www.evoss.net) offers electric motorcycles to work and have fun in the USA, Spain, Portugal, Panama, Colombia, and Venezuela. EVOSS is also working on the development of an EV Mid Speed Car to serve the niche of the 2nd car in the family.
3. $EDXC – Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from the cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving.
4. $MLRT – MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling, and licensing products, services, and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with movement, cognitive, and spatial awareness disorders. This market represents approximately 2.9% of the world’s population. The Company offers global end-to-end hardware, software, and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, and enterprise and government agency applications. Utilizing the latest in miniaturized, low power consumption GPS, Cellular, RF, NFC, and BLE technologies, enabling caregivers to track and monitor patients in real-time. Known for its game-changing and award-winning patented GPS SmartSole® — think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. Military Government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers.
These four emerging OTC stocks are all poised for growth, with innovative business models and a focus on the future. Whether you are looking for a high-growth investment opportunity or seeking to diversify your portfolio, these stocks are definitely worth considering.
Heads up, investors! Intel’s earnings are shrinking, but that doesn’t mean your investment opportunities have to as well. Take a look at these four emerging OTC stocks for a high-growth opportunity. $LUDG, $IQST, $EDXC, and $MLRT are all poised for success in the coming years and are well worth considering for your investment portfolio.
Featured: $LUDG $IQST $EDXC $MLRT